An integrated safety analysis of lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, in subjects with knee osteoarthritis

• Published in: Osteoarthritis and cartilage Vol. 28; pp. S376 - S377
• Main Authors: Simsek, I., Swearingen, C.J., Kennedy, S., Tambiah, J., Yazici, Y., Lane, N.E., Hochberg, M.C.
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.04.2020
• Subjects: Rheumatology